Latest news about Sat Kartar Life
Sat Kartar Life
136.00
+0.90(+0.67%)
Company Performance:
View Company Insights1D+0.67%
1M-15.11%
6M-2.16%
1Y-26.07%
5Y-15.82%
More news about Sat Kartar Life
10May 26
Sat Kartar Life Limited Receives NSE In-Principle Approval for Equity Share Issuance via Warrant Conversion
Sat Kartar Life Limited has received NSE in-principle approval under Regulation 28(1) of SEBI (LODR) Regulations, 2015, for the issuance of 50,400 equity shares and 27,74,400 equity shares of Rs. 10/- each, to be allotted upon conversion of warrants issued through a preferential issue. The approval was granted vide NSE letter Ref. No. NSE/LIST/54702 dated May 08, 2026, following the company's application submitted on April 21, 2026. The approval is conditional upon the company meeting several regulatory, statutory, and compliance requirements, including strengthening internal controls over allottee trading activity. The NSE has reserved the right to withdraw the approval if any submitted information is found to be incomplete, incorrect, or in violation of applicable rules.
09May 26
Sat Kartar Life Limited Expands into Curated Spiritual Offerings and Wellness-Related Products
Sat Kartar Life Limited disclosed on May 8, 2026, the adoption of a new line of business in curated spiritual offerings and wellness-related products, filed under Regulation 30 of the SEBI (LODR) Regulations, 2015. The new business encompasses manufacturing, trading, and retailing of spiritual products such as rudraksha beads, gemstones, yantras, and puja items, along with spiritual consultation, meditation programs, and publishing services. The company expects the new activity to leverage its existing digital reach, customer engagement capabilities, and distribution infrastructure, contributing to revenue growth and improved market positioning. The estimated investment amount remains to be determined based on project feasibility and market conditions.
07May 26
Sat Kartar Life Limited Receives NSE No-Objection for Reclassification of SK Sarthi Private Limited from Promoter Group to Public Category
Sat Kartar Life Limited (formerly known as Sat Kartar Shopping Limited) has received a no-objection letter from NSE vide Ref. No. NSE/LIST/COMP/SATKARTAR/554/2026-27, dated May 06, 2026, for reclassifying SK Sarthi Private Limited from the 'Promoter Group' to the 'Public' category under Regulation 31A of SEBI LODR Regulations, 2015. The application for reclassification was originally submitted on January 28, 2026. Since SK Sarthi Private Limited holds less than 1% of the company's paid-up share capital, shareholder approval is not required for this reclassification.
07May 26
Sat Kartar Life FY26 PAT Surges 74.31% to ₹17.10 Cr; Targets ₹500 Cr Revenue by FY28
Sat Kartar Life reported a 23.19% YoY increase in FY26 revenue to ₹200.70 Cr and a 74.31% surge in PAT to ₹17.10 Cr. EBITDA rose 73.51% to ₹24.69 Cr with margin expansion. The company announced strategic initiatives including a preferential issue of ₹48.58 Cr, a partnership with Jeena Sikho Lifecare, and the acquisition of Plantomed Neutraceuticals. Management targets ₹500 Cr revenue by FY28.
05May 26
Sat Kartar Life Limited Promoters Declare No Share Encumbrance for Financial Year Ended March 31, 2026
Sat Kartar Life Limited (formerly Sat Kartar Shopping Limited) has filed a declaration with NSE confirming that its promoters and persons acting in concert have not made any encumbrance on their shares for the financial year ended March 31, 2026. The declaration was submitted by promoter Manprit Singh Chadha on April 1, 2026, and forwarded to NSE by Company Secretary Sonal Seth on April 3, 2026. The filing is in accordance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Cipla
Zydus Life Science
Lupin
Mankind Pharma
Dr Reddys Laboratories
Aurobindo Pharma
Laurus Labs
1,938.60
(-0.01%)
6,829.00
(+0.23%)
4,878.50
(-0.40%)
1,445.90
(+0.32%)
1,154.40
(-0.40%)
2,505.60
(+0.09%)
2,551.20
(+0.76%)
1,244.50
(-1.35%)
1,565.90
(-1.35%)
1,540.40
(+2.19%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
